Edition:
United States

Glenmark Pharmaceuticals Ltd (GLEN.NS)

GLEN.NS on National Stock Exchange of India

860.95INR
29 Jul 2016
Change (% chg)

Rs9.50 (+1.12%)
Prev Close
Rs851.45
Open
Rs857.85
Day's High
Rs864.75
Day's Low
Rs851.25
Volume
452,246
Avg. Vol
598,976
52-wk High
Rs1,262.90
52-wk Low
Rs671.10

Reports per page
Select Report Title Date Provider Pgs Price
Thomson Reuters Stock Report - Glenmark Pharmaceuticals Ltd (GLENMARK-IN) 29 Jul 2016 Thomson Reuters Stock Report 11 25.00
Glenmark Pharmaceuticals Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. 22 Jul 2016 Reuters Investment Profile 12 20.00
Glenmark Pharmaceuticals Ltd. (GLENMARK) - Financial Analysis Review 21 Jul 2016 GlobalData 59 300.00
Spark Capital: Glenmark Pharmaceuticals – FY16 annual report analysis 20 Jul 2016 Spark Capital Advisors(India) Private Limited 7 58.00
Glenmark Pharmaceuticals Ltd: Downgraded to Average 14 Jul 2016 Sadif Analytics Prime 3 10.00
Wright Investors Service Comprehensive Report for Glenmark Pharmaceuticals Ltd 11 Jul 2016 Wright Reports 60 75.00
 
Name Age Since Current Position

Glenn Saldanha

46 2011 Executive Chairman of the Board, Chief Executive Officer, Managing Director

P. Ganesh

2016 President, Chief Financial Officer

Sanjay Chowdhary

2015 Compliance Officer, Company Secretary

Cherylann Pinto

Director - Corporate Affairs, Executive Director

Rajesh Desai

52 2016 Executive Director